Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. O. Rodriguez
Carboplatin Versus Alternating Carboplatin and Doxorubicin for the Adjuvant Treatment of Canine Appendicular Osteosarcoma: A Randomized, Phase III Trial
Veterinary and Comparative Oncology
Veterinary
Interatomic Forces and Atomic Structure of Grain Boundaries in Copper-Bismuth Alloys
Physical Review B
Related publications
A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Bone Allografts and Adjuvant Cisplatin for the Treatment of Canine Appendicular Osteosarcoma in 18 Dogs
Journal of Small Animal Practice
Small Animals
Phase I Trial of Combretastatin A-4 Phosphate With Carboplatin
Clinical Cancer Research
Cancer Research
Oncology
Doxorubicin and 5-Fluorouracil Versus Doxorubicin and Oral Ftorafur in the Treatment of Advanced Gastric Cancer—a Phase II and III Trial
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Randomized Phase II Trial of Paclitaxel and Carboplatin Followed by Gemcitabine Switch-Maintenance Therapy Versus Gemcitabine and Carboplatin Followed by Gemcitabine Continuation-Maintenance Therapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Phase 2 Trial of Neoadjuvant Bevacizumab Plus Pemetrexed and Carboplatin in Patients With Unresectable Stage III Lung Adenocarcinoma (GASTO 1001)
Cancer
Cancer Research
Oncology
A Phase II Trial of Gemcitabine Plus Carboplatin in Advanced Transitional Cell Carcinoma of the Urothelium
BMC Cancer
Cancer Research
Oncology
Genetics
Long-Term Complete Remission After Treatment With Doxorubicin, Carboplatin and Piroxicam in a Dog With Orbital Chondrosarcoma
Journal of the Japan Veterinary Medical Association
Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients With Extensive-Stage Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary